Advertisements
Etawo and Aleme
|
Greener Journal of Medical Sciences Vol. 11(2), pp. 137-142, 2021 ISSN: 2276-7797 Copyright ©2021, the copyright of this article is retained by the author(s) |
|
Assessment of Hypogonadism in Men with Type 2 Diabetes Mellitus
Etawo U.S*; Aleme B.M**
Departments of Surgery* and Chemical Pathology**
University of Port Harcourt Teaching Hospital, PMB 6173, Port Harcourt
|
ARTICLE INFO |
|
|
|||||||
|
Article No.:101421104 Type: Research
|
Accepted: 14/10/2021 Published: 18/10/2021 |
*Corresponding Author Dr. U S Etawo E-mail: dr_etawo@yahoo.com Phone: +234 803 312 2701
|
Keywords: Diabetes Mellitus; Hypogonadism; Testosterone
|
|
|||||
|
ABSTRACT |
|
|
|||||||
|
Background: There is an established relationship between type 2 diabetes and Hypogonadism. Testosterone, the main gonadal steroid in men is lower in diabetic men when compared with healthy subjects. Currently, very few diabetic men with testosterone deficiency are diagnosed and treated worldwide. Knowledge of testosterone levels of patients will reveal those with androgen deficiency so that appropriate treatment will be offered. Objective: The aim of this study was to assess the prevalence of Hypogonadism based on biochemical measures of total testosterone deficiency in men with type 2 diabetes in Port Harcourt. Methods: Type 2 diabetic patients attending the Medical Out-Patient Clinic of University of Port Harcourt Teaching Hospital (UPTH) between April and May, 2012 were used for this study. Fasting blood sugar was measured using Randox kit, Testosterone was measured using Enzyme Linked Immunoassay. Data were analyzed using the SPSS package (Version 20.0.0). The mean levels of testosterone for the patients as a group and also according to age, glycemic state and duration of disease were computed. Values were expressed as a percentage of each group or as mean + 2SD. Comparisons between groups were made using the student t-test at 95% confidence interval. Results were significant if P < 0.05. Results: One hundred and forty two (142) patients were tested within the study period. 31.7% (45) of the 142 diabetic patients had a lower than normal testosterone level (Testosterone<3.0ng/ml). The mean testosterone levels decreased significantly in the older men (>70 years). The percentages of patients with low testosterone levels were increasingly higher as the age increased. 10.7% of patients aged 41-50 years had low testosterone levels. Their mean was 3.51+ 0.54 ng/ml. 12.8% of patients aged 51-60 years had low testosterone and their mean level was 3.35+0.58 ng/ml. 25.0% of the patients aged 61-70 years had low testosterone levels. Their mean was 2.89+0.68, while 92.3 of the patients >70 years had low testosterone with a mean of 1.57+0.70 ng/ml. The percentage of patients with low testosterone was not altered by the degree of rise in blood sugar level. 32.2% of the patients whose fasting blood glucose level were <10.0mmol/L had low testosterone levels and their mean was 2.99+0.83ng/ml while 28.0% of the patients with fasting blood glucose level >10mmol/L had low testosterone levels and their mean was 3.0+0.67 ng/ml. There was no significant difference between the two groups. 17.4% of the patients whose disease has lasted for 1-5 years had low testosterone level and their mean was 3.27+0.58 ng/ml while 74.1% of the patients with disease duration between 6-10 years had low testosterone levels and a mean of 2.23+0.78ng/ml. 83.3% of the patients with disease duration >10years had low testosterone levels and their mean level was 1.62+1.81ng/ml. Conclusion: Testosterone levels are low in type 2 diabetic men. These levels are further affected by age and duration of disease. Glycemic status had no statistically significant. |
|
||||||||
|
|
|
|
|
|
|
||||
Return to Content View [Full Article - PDF] |
REFERENCES
1. Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006; 154:899–906.
2. Kapoor D, Aldred H, Clarck S, Chanee K and Jones T.H. Clinical and Biochemical Assessment of Hypogonadism in Men with Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007; 30(4): 911-917.
3. Seftel A. Male Hypogonadism. Part II: Etiology, Pathophysiology, and Diagnosis. Int. J Impot Res. 2006; 18(3):223-228.
4. Carnegie C. Diagnosis of Hypogonadism: Clinical Assessments and Laboratory Tests. Rev. Urol. 2004; 6(6): S3-S8.
5. Kapoor D, Malkin CJ, Channer KS, Jones TH: Androgens, insulin resistance and vascular disease in men. ClinEndocrinol (Oxf ). 2005; 63: 239–250.
6. Simon D, Preziosi P, Barrett-Connor E, Roger M, Saint-Paul M, Nahoul K, Papoz L: Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study. Diabetologia. 1992; 35:173–177.
7. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL: Endogenous sex hormones and the development of type 2 diabetes in older men and women. Diabetes Care. 2002; 25:55–60.
8. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone binding globulin and the development of type 2 diabetes in middle aged men. Diabetes Care. 2000; 23:490–494.
9. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone binding globulin and testosterone predict the development of non insulin dependent diabetes mellitus in men. Am J Epidemiol. 1996; 143:889–897.
10. Barrett-Connor E, Khaw KT, Yen SS: Endogenous sex hormone levels in older men with diabetes mellitus. Am J Epidemiol. 1990; 132:895–901.
11. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P: Testosterone concentrations in women and men with NIDDM. Diabetes Care 17:405–411, 1994
12. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J ClinEndocrinolMetab. 1983; 56(6):1278–1281.
13. Simon D, Charles MA, Lahlou N, Nahoul K, Oppert JM, Gouault-Heilmann M, Lemort N, Thibult N, Joubert E, Balkau B, Eschwege E: Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone. Diabetes Care. 2001; 24:2149–2151.
14. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P: The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J ObesRelatMetabDisord. 1992; 16:991–997.
15. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropichypogonadism in type 2 diabetes. J ClinEndocrinolMetab. 2004; 89:5462–5468.
16. Ogbera OA, Sonny C, Olufemi F, Wale A: Hypogonadism and Subnormal levels in men with type 2 diabetes mellitus. J coll Physicians Surg Pak. 2011; 21(9):517-21.
17. SaadFarid and Gooren J. L. The role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome and Diabetes Mellitus Type 2. Journal of Obesity. www.hindawi.com/journals/jobes/2011/471584/abs/
18. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF: The prevalence of diabetic impotence. Diabetologia. 1980; 18:279–283.
19. Leifke E, Gorenoi V, Wichers C, Muhlen A, Buren E, Brabant G: Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf). 2000; 53:689–695.
|
Cite this Article: Etawo, US; Aleme, BM (2021). Assessment of Hypogonadism in Men with Type 2 Diabetes Mellitus. Greener Journal of Medical Sciences, 11(2): 137-142.
|
Call for Papers
Call for Scholarly Articles
Authors from around the world are invited to send scholary articles that suits the scope of this journal. The journal is currently open to submissions and will process and publish articles monthly in two yearly issues.
The journal is centered on quality and goes about its processes in a very timely fashion. Seasoned editors/reviewers will be consulted to review each article(s), profer quality evaluations and polish the articles with expertise before publication.
Simply send your article(s) as an e-mail attachment to manuscripts@acad.gjournals.org or manuscripts.igj@gmail.com.
Advertisements
